105 related articles for article (PubMed ID: 26295164)
1. Stereospecific Inhibitory Effects of CCG-1423 on the Cellular Events Mediated by Myocardin-Related Transcription Factor A.
Watanabe B; Minami S; Ishida H; Yoshioka R; Nakagawa Y; Morita T; Hayashi K
PLoS One; 2015; 10(8):e0136242. PubMed ID: 26295164
[TBL] [Abstract][Full Text] [Related]
2. RPEL proteins are the molecular targets for CCG-1423, an inhibitor of Rho signaling.
Hayashi K; Watanabe B; Nakagawa Y; Minami S; Morita T
PLoS One; 2014; 9(2):e89016. PubMed ID: 24558465
[TBL] [Abstract][Full Text] [Related]
3. Suppression of Epithelial-Mesenchymal Transition in Retinal Pigment Epithelial Cells by an MRTF-A Inhibitor.
Kobayashi M; Tokuda K; Kobayashi Y; Yamashiro C; Uchi SH; Hatano M; Kimura K
Invest Ophthalmol Vis Sci; 2019 Feb; 60(2):528-537. PubMed ID: 30707754
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological Inhibition of Myocardin-related Transcription Factor Pathway Blocks Lung Metastases of RhoC-Overexpressing Melanoma.
Haak AJ; Appleton KM; Lisabeth EM; Misek SA; Ji Y; Wade SM; Bell JL; Rockwell CE; Airik M; Krook MA; Larsen SD; Verhaegen M; Lawlor ER; Neubig RR
Mol Cancer Ther; 2017 Jan; 16(1):193-204. PubMed ID: 27837031
[TBL] [Abstract][Full Text] [Related]
5. Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis.
Yu-Wai-Man C; Spencer-Dene B; Lee RMH; Hutchings K; Lisabeth EM; Treisman R; Bailly M; Larsen SD; Neubig RR; Khaw PT
Sci Rep; 2017 Mar; 7(1):518. PubMed ID: 28364121
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosis.
Sisson TH; Ajayi IO; Subbotina N; Dodi AE; Rodansky ES; Chibucos LN; Kim KK; Keshamouni VG; White ES; Zhou Y; Higgins PD; Larsen SD; Neubig RR; Horowitz JC
Am J Pathol; 2015 Apr; 185(4):969-86. PubMed ID: 25681733
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological intervention of MKL/SRF signaling by CCG-1423 impedes endothelial cell migration and angiogenesis.
Gau D; Veon W; Capasso TL; Bottcher R; Shroff S; Roman BL; Roy P
Angiogenesis; 2017 Nov; 20(4):663-672. PubMed ID: 28638990
[TBL] [Abstract][Full Text] [Related]
8. CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling.
Evelyn CR; Wade SM; Wang Q; Wu M; Iñiguez-Lluhí JA; Merajver SD; Neubig RR
Mol Cancer Ther; 2007 Aug; 6(8):2249-60. PubMed ID: 17699722
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of endothelial-to-mesenchymal transition in cardiac fibrosis: role of myocardin-related transcription factor A and activating transcription factor 3.
Sharma V; Dogra N; Saikia UN; Khullar M
Can J Physiol Pharmacol; 2017 Oct; 95(10):1263-1270. PubMed ID: 28686848
[TBL] [Abstract][Full Text] [Related]
10. Matrix stiffness regulates epithelial-mesenchymal transition via cytoskeletal remodeling and MRTF-A translocation in osteosarcoma cells.
Dai J; Qin L; Chen Y; Wang H; Lin G; Li X; Liao H; Fang H
J Mech Behav Biomed Mater; 2019 Feb; 90():226-238. PubMed ID: 30384218
[TBL] [Abstract][Full Text] [Related]
11. miR-219a-5p inhibits breast cancer cell migration and epithelial-mesenchymal transition by targeting myocardin-related transcription factor A.
Zhuang C; Yuan Y; Song T; Wang H; Huang L; Luo X; He H; Huo L; Zhou H; Wang N; Zhang T
Acta Biochim Biophys Sin (Shanghai); 2017 Dec; 49(12):1112-1121. PubMed ID: 29077787
[TBL] [Abstract][Full Text] [Related]
12. Optimization of novel nipecotic bis(amide) inhibitors of the Rho/MKL1/SRF transcriptional pathway as potential anti-metastasis agents.
Bell JL; Haak AJ; Wade SM; Kirchhoff PD; Neubig RR; Larsen SD
Bioorg Med Chem Lett; 2013 Jul; 23(13):3826-32. PubMed ID: 23707258
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory selectivity among class I HDACs has a major impact on inflammatory gene expression in macrophages.
Cao F; Zwinderman MRH; van Merkerk R; Ettema PE; Quax WJ; Dekker FJ
Eur J Med Chem; 2019 Sep; 177():457-466. PubMed ID: 31181405
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and prostate cancer cell-based studies of analogs of the Rho/MKL1 transcriptional pathway inhibitor, CCG-1423.
Evelyn CR; Bell JL; Ryu JG; Wade SM; Kocab A; Harzdorf NL; Showalter HD; Neubig RR; Larsen SD
Bioorg Med Chem Lett; 2010 Jan; 20(2):665-72. PubMed ID: 19963382
[TBL] [Abstract][Full Text] [Related]
15. Profibrotic epithelial phenotype: a central role for MRTF and TAZ.
Bialik JF; Ding M; Speight P; Dan Q; Miranda MZ; Di Ciano-Oliveira C; Kofler MM; Rotstein OD; Pedersen SF; Szászi K; Kapus A
Sci Rep; 2019 Mar; 9(1):4323. PubMed ID: 30867502
[TBL] [Abstract][Full Text] [Related]
16. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells induce epithelial mesenchymal transition in melanoma by paracrine secretion of transforming growth factor-β.
Lv C; Dai H; Sun M; Zhao H; Wu K; Zhu J; Wang Y; Cao X; Xia Z; Xue C
Melanoma Res; 2017 Apr; 27(2):74-84. PubMed ID: 28079609
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo delivery of a sustained release nanocarrier-based formulation of an MRTF/SRF inhibitor in conjunctival fibrosis.
Tagalakis AD; Madaan S; Larsen SD; Neubig RR; Khaw PT; Rodrigues I; Goyal S; Lim KS; Yu-Wai-Man C
J Nanobiotechnology; 2018 Nov; 16(1):97. PubMed ID: 30482196
[TBL] [Abstract][Full Text] [Related]
19. Tumor Progression Is Mediated by Thymosin-β4 through a TGFβ/MRTF Signaling Axis.
Morita T; Hayashi K
Mol Cancer Res; 2018 May; 16(5):880-893. PubMed ID: 29330296
[TBL] [Abstract][Full Text] [Related]
20. Cdc42 regulates myocardin-related transcription factor nuclear shuttling and alpha-smooth muscle actin promoter activity during renal tubular epithelial-mesenchymal transition.
Sebe A; Erdei Z; Varga K; Bodor C; Mucsi I; Rosivall L
Nephron Exp Nephrol; 2010; 114(3):e117-25. PubMed ID: 20016221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
